Is ARVL or MRK a better dividend investment in 2026?

ARVL currently yields 408.16% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: ARVL offers higher current income.

What is the dividend yield difference between ARVL and MRK?

ARVL has a forward dividend yield of 408.16% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 405.40 percentage points.

Home › Compare › ARVL vs MRK

ARVL vs MRK: Dividend Comparison 2026

ARVL yields 408.16% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARVL wins by $13266.29M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARVL

● Live price

408.16%

Share price

$0.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$13266.35M

Annual income

$8,951,942,333.18

Full ARVL calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — ARVL vs MRK

📍 ARVL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARVL	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARVL + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARVL pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARVL

Annual income on $10K today (after 15% tax)

$34,693.88/yr

After 10yr DRIP, annual income (after tax)

$7,609,150,983.20/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, ARVL beats the other by $7,609,142,654.79/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARVL + MRK for your $10,000?

ARVL: 50%MRK: 50%

100% MRK50/50100% ARVL

Portfolio after 10yr

$6633.20M

Annual income

$4,475,976,065.66/yr

Blended yield

67.48%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ARVL

Analyst Ratings

Buy

Consensus: Buy

Altman Z

0.0

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARVL buys

MRK buys

No recent congressional trades found for ARVL or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARVLMRK

Forward yield	408.16% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$13266.35M ✓	$56.8K
Annual income after 10y	$8,951,942,333.18 ✓	$9,798.13
Total dividends collected	$12871.54M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: ARVL vs MRK ($10,000, DRIP)

Year	ARVL Portfolio	ARVL Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$51,516	$40,816.33	$11,206	$366.19	+$40.3K → ARVL
2	$251,637	$196,514.69	$12,650	$502.35	+$239.0K → ARVL
3	$1,166,352	$897,100.58	$14,407	$694.19	+$1.15M → ARVL
4	$5,134,082	$3,886,085.48	$16,585	$967.82	+$5.12M → ARVL
5	$21,480,272	$15,986,803.86	$19,342	$1,363.89	+$21.46M → ARVL
6	$85,494,655	$62,510,763.88	$22,913	$1,947.19	+$85.47M → ARVL
7	$324,004,581	$232,525,300.29	$27,662	$2,823.89	+$323.98M → ARVL
8	$1,170,251,307	$823,566,405.33	$34,159	$4,173.35	+$1170.22M → ARVL
9	$4,032,156,309	$2,779,987,409.90	$43,337	$6,308.80	+$4032.11M → ARVL
10	$13,266,349,583	$8,951,942,333.18	$56,776	$9,798.13	+$13266.29M → ARVL

ARVL vs MRK: Complete Analysis 2026

ARVL — Stock

Arrival engages in the research and development, and design of commercial electric vehicles (EVs), EVs components, robotic manufacturing processes for EVs, and associated software in the United Kingdom, the United States, Russia, and internationally. Its products portfolio includes commercial EV vans, buses, and cars. The company was formerly known as Arrival Group S.A. and changed its name to Arrival. The company was founded in 2015 and is based in Howald, Luxembourg. Arrival is a subsidiary of Kinetik S.à r.l.

Full ARVL Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this ARVL vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARVL vs SCHD ARVL vs JEPI ARVL vs O ARVL vs KO ARVL vs MAIN ARVL vs JNJ ARVL vs ABBV ARVL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.